KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,092 filers reported holding BAXTER INTL INC in Q1 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$2,096,532
-22.1%
55,552
-6.0%
0.01%
-25.0%
Q2 2023$2,692,596
+6.6%
59,100
-5.1%
0.01%
+14.3%
Q1 2023$2,525,428
+10.2%
62,264
+38.5%
0.01%0.0%
Q4 2022$2,292,223
+114511.2%
44,972
+154975.9%
0.01%
Q4 2019$2,000
-100.0%
29
-100.0%
0.00%
-100.0%
Q3 2016$4,399,000
+17.3%
92,418
+11.4%
0.06%
-3.5%
Q2 2016$3,750,000
+22.3%
82,939
+11.2%
0.06%
+14.0%
Q1 2016$3,065,000
+54.2%
74,609
+43.2%
0.05%
+51.5%
Q4 2015$1,988,000
+139.2%
52,109
+106.1%
0.03%
+135.7%
Q3 2015$831,000
-93.7%
25,288
-85.9%
0.01%
-93.9%
Q1 2014$13,162,000
+7.1%
178,883
+1.2%
0.23%
+11.7%
Q4 2013$12,289,000
+7.6%
176,686
+1.6%
0.21%
-3.7%
Q3 2013$11,425,000
-6.4%
173,919
-1.3%
0.21%
-13.4%
Q2 2013$12,211,000176,2770.25%
Other shareholders
BAXTER INTL INC shareholders Q1 2020
NameSharesValueWeighting ↓
JONES ROAD CAPITAL MANAGEMENT, L.P. 200,000$7,548,0006.60%
BOONE CAPITAL MANAGEMENT LLC 469,405$17,715,3455.59%
Soditic Asset Management LLP 186,920$7,054,3615.43%
JONES ROAD CAPITAL MANAGEMENT, L.P. 131,000$4,943,9404.32%
Camber Capital Management LP 3,000,000$113,2203.73%
Carmignac Gestion 4,848,773$182,991,7183.36%
SHAPIRO CAPITAL MANAGEMENT LLC 3,028,799$114,306,8743.33%
Hillman Capital Management, Inc. 219,248$8,274,4203.19%
Cincinnati Specialty Underwriters Insurance CO 201,500$7,604,6102.90%
Callodine Capital Management, LP 265,000$10,001,1002.79%
View complete list of BAXTER INTL INC shareholders